Shire Finds Another Orphan Opportunity, Licenses Acceleron's DMD Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
The deal gives the Irish pharma rights outside the U.S. and Canada to an entire family of proteins that address muscle disorders.